ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Thrombotic Microangiopathy after Renal Transplantation: A Clinicopathological Study and Identification of Prognostic Factors

K. Dessaix,1 C. Bontoux,2 O. Aubert,1 J. Zuber,1 R. Sberro Soussan,1 V. Frémeaux-Bacchi,3 M. Le Quintrec,4 C. Legendre,1 M. Rabant.2

1Renal Transplantation Department, Necker-Enfants Malades Hospital, Paris, France
2Pathology Department, Necker-Enfants Malades Hospital, Paris, France
3Immunology Laboratory, Georges Pompidou European Hospital, Paris, France
4Nephrology Department, CHU Montpellier, Montpellier, France.

Meeting: 2018 American Transplant Congress

Abstract number: 315

Keywords: Hemolytic-uremic syndrome, Kidney transplantation, Prognosis

Session Information

Date: Monday, June 4, 2018

Session Name: Concurrent Session: Kidney Complications: Diagnostic Considerations

Session Time: 4:30pm-6:00pm

 Presentation Time: 5:42pm-5:54pm

Location: Room 6C

Related Abstracts
  • High Prevalence of Kidney Transplant-Associated Thrombotic Microangiopathy after ABO-Incompatible Kidney Transplantation: Risk Factors, Rapid Clinical Diagnosis, and Prompt Successful Treatment
  • Significance of Thrombotic Microangiopathy in Renal Allografts.

Introduction

Thrombotic microangiopathy (TMA), whether de novo or recurrent, is a serious complication after renal transplantation, but prognostic factors and the role of complement inhibitors in the therapeutic strategy regarding de novo TMA are yet to be determined.

Methods

We retrospectively included all the patients with histopathologic lesions of TMA on for cause and/or screening kidney allograft biopsies performed between January 2004 and March 2016 in our center. The aims of our study were the description of clinicopathologic features and the identification of prognostic factors of de novo TMA.

Results

98 patients experienced at least one episode of histological TMA, among which 90 % were de novo, (4,8% of the total kidney transplant population in our center). The median time of occurrence was 198±920 days. The majority (83,7%) of cases were TMA localized in the graft. The etiological factors were multiple in more than one-third of cases, antibody-mediated rejection being the most frequent cause (46,9%), whereas underlying abnormalities of the alternative complement pathway were proved or suspected in 10,2 % of de novo TMA, even in localized forms. Graft survival was worst compared to kidney transplant recipients without TMA (84.7% vs 91.3% after 5 years respectively ; p<0.0001). The rate of graft loss after one year among patients with de novo TMA and recurrent TMA was 8 % and 10% respectively. The 2 main factors associated with graft loss were score of intimal arteritis and renal function at the time of diagnosis. The histological pattern of TMA was not discriminative of any etiology, even if arteriolar pattern and glomerular pattern were more often associated with calcineurin-inhibitor toxicity and antibody-mediated rejection respectively.

Conclusion

These results confirm the theory of the " multiple hit " with often multiple causal factors and the implication of alternative complement pathway dysregulation in the pathogenesis of some cases of de novo TMA. It also underlines the prognostic value of histology but its current limits to provide the clinician with etiologic clues.

CITATION INFORMATION: Dessaix K., Bontoux C., Aubert O., Zuber J., Sberro Soussan R., Frémeaux-Bacchi V., Le Quintrec M., Legendre C., Rabant M. Thrombotic Microangiopathy after Renal Transplantation: A Clinicopathological Study and Identification of Prognostic Factors Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Dessaix K, Bontoux C, Aubert O, Zuber J, Soussan RSberro, Frémeaux-Bacchi V, Quintrec MLe, Legendre C, Rabant M. Thrombotic Microangiopathy after Renal Transplantation: A Clinicopathological Study and Identification of Prognostic Factors [abstract]. https://atcmeetingabstracts.com/abstract/thrombotic-microangiopathy-after-renal-transplantation-a-clinicopathological-study-and-identification-of-prognostic-factors/. Accessed March 6, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Home
  • Search
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.